Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-007548
Filing Date
2025-03-03
Accepted
2025-03-03 16:46:16
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 16799
  Complete submission text file 0001127602-25-007548.txt   18321
Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Issuer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 200 TECHNOLOGY SQUARE SUITE 300 CAMBRIDGE MA 02139
Business Address
Klinger Shannon Thyme (Reporting) CIK: 0001866132 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38753 | Film No.: 25698816